Whipple's disease diagnosis following the use of TNF-α blockade

Rheumatology

Volumn 51, Issue 5, 2012, Pages 946-

  Gaddy, Jasmine R ^a,b   Khan, Zartash Z ^c,d   Chaser, Brad ^a   Scofield, R Hal ^b,c,e  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

^c UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^d Infectious Disease Consultants   (United States)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; CEFTRIAXONE; COTRIMOXAZOLE; HLA B27 ANTIGEN; INFLIXIMAB; METHOTREXATE; PREDNISONE;

ABNORMAL LABORATORY RESULT; ACTINOBACTERIA; ADULT; ANAMNESIS; ARTHRITIS; BACKACHE; CASE REPORT; DIARRHEA; DUODENUM BIOPSY; ERYTHROCYTE SEDIMENTATION RATE; FEVER; HUMAN; INFLAMMATORY BACK PAIN; INTESTINE LIPODYSTROPHY; MALE; MIGRATORY ARTHRITIS; NOTE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RADIOGRAPHY; RANGE OF MOTION; TROPHERYMA WHIPPLEI; WEIGHT REDUCTION;

ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL; HUMANS; MALE; MIDDLE AGED; SPONDYLITIS, ANKYLOSING; TUMOR NECROSIS FACTOR-ALPHA; WHIPPLE DISEASE;

EID: 84860235924     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/ker387     Document Type: Note

References (2)

1. Schneider T, Moos V, Loddenkemper C et al. Whipple's disease: New aspects of pathogenesis and treatment. Lancet Infect Dis 2008;8:179-90.
2. Kneitz C, Suerbaum S, Beer M et al. Exacerbation of Whipple's disease associated with infliximab treatment. Scand J Rheumatol 2005;34:148-51.